戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y hospitals, and 6 from referrals because of clinical symptoms).
2 ngo (DRC) and correlated these findings with clinical symptoms.
3 ies for multienzyme complexes and eventually clinical symptoms.
4 degeneration, and ranges from mild to severe clinical symptoms.
5  expression, which may underline some shared clinical symptoms.
6  intestinal tract without inducing any overt clinical symptoms.
7 features, including age at disease onset and clinical symptoms.
8 te patella and evaluate the association with clinical symptoms.
9 rent developmental periods when interpreting clinical symptoms.
10 y, enabling real-time response to concerning clinical symptoms.
11  levels of pain, psychological measures, and clinical symptoms.
12 ent and only diagnosed upon manifestation of clinical symptoms.
13 ion between SN-centered network dynamics and clinical symptoms.
14 athy being the proteinopathy associated with clinical symptoms.
15 es for a limited time but without noticeable clinical symptoms.
16 of major functional disability, with minimal clinical symptoms.
17 related differentially, across regions, with clinical symptoms.
18 ty of the immune system, leading to variable clinical symptoms.
19 n of AD pathology triggers the expression of clinical symptoms.
20 nB13 IgG responses, before the appearance of clinical symptoms.
21 evaluate putative efficacy in the absence of clinical symptoms.
22 ology even prior to the development of overt clinical symptoms.
23 hey had a normal physical exam and/or lacked clinical symptoms.
24  considerable patient-patient variability in clinical symptoms.
25  at an early stage before the development of clinical symptoms.
26  genetic links, consistent with the onset of clinical symptoms.
27 improve perception, learning, and a range of clinical symptoms.
28 72.4%) reported a significant alleviation of clinical symptoms.
29 on of liver enzymes, and amelioration of any clinical symptoms.
30 in serum sodium alone is a poor predictor of clinical symptoms.
31 ctions, beyond the influence of cortisol and clinical symptoms.
32 observed in 9 children, in 7 associated with clinical symptoms.
33 ons, which leads to diverse and debilitating clinical symptoms.
34 l phenotypes that contribute to NDD risk and clinical symptoms.
35 nd is not beneficial in terms of alleviating clinical symptoms.
36 improve perception, learning, and a range of clinical symptoms.
37 s harboring activated donor T cells prior to clinical symptoms.
38 examination 43-year-old male patient without clinical symptoms.
39 id-beta plaques correlate with cognition and clinical symptoms.
40 g six patients with and two patients without clinical symptoms.
41 urther studies are needed for the effects on clinical symptoms.
42  pet IgE components and its association with clinical symptoms.
43 e presence of bacteriuria in relation to the clinical symptoms.
44 pment and its functional implications in ASD clinical symptoms.
45 scites or encephalopathy or other associated clinical symptoms.
46 etermine factors that confer protection from clinical symptoms.
47 <1.5 x 109/L at one month and improvement of clinical symptoms.
48 ventable and treatable prior to the onset of clinical symptoms.
49 ctor in determining the age at onset (AO) of clinical symptoms.
50 and Negative Syndrome Scale was utilized for clinical symptoms.
51  but 1 patient experienced an improvement of clinical symptoms.
52 isorder with marked gastric eosinophilia and clinical symptoms.
53  latent dimensions of brain connectivity and clinical symptoms.
54 f frontal-subcortical dysfunction with other clinical symptoms.
55 -positive (ANA+) and most will never develop clinical symptoms.
56 ween these two conditions after the onset of clinical symptoms.
57 pationally exposed subjects with and without clinical symptoms.
58 artemether-lumefantrine after development of clinical symptoms.
59 tum corneum proteins, even in the absence of clinical symptoms.
60  be useful for the differential diagnosis of clinical symptoms.
61 ificantly decrease the time to resolution of clinical symptoms.
62 esulted in rapid resolution of the patient's clinical symptoms.
63 ignificant reduction of temperature drop and clinical symptoms, 60 minutes after challenge.
64  syndromes that occur in MS and describe the clinical symptoms, aetiology, neuroimaging findings and
65 e intolerance is thought to trigger manifold clinical symptoms after ingesting histamine-rich food du
66 s a systemic immune response associated with clinical symptoms after NAC.
67  imaging studies must be correlated with the clinical symptoms after other more common causes that ca
68 rone cellular phenotypes and of prototypical clinical symptoms allows a new conceptual framework for
69                          Also of importance, clinical symptoms alone do not distinguish viral from ba
70                 The diagnosis of AD based on clinical symptoms alone is known to have poor specificit
71 o start years in advance of manifestation of clinical symptoms, although the exact timing is unknown.
72 ed to examine P50 suppression in relation to clinical symptom and cognitive performance measures.
73          Malaria and dengue have overlapping clinical symptoms and are prevalent in the same geograph
74 ty in depression, with consideration of both clinical symptoms and behaviors (symptomatology and traj
75 anaged with a tight control algorithm, using clinical symptoms and biomarkers, versus patients manage
76 lergens locally to the nasal mucosa allowing clinical symptoms and biospecimens such as peripheral bl
77 imals completely prevents the development of clinical symptoms and brain damage.
78 eatment for SCA38, showing an improvement of clinical symptoms and cerebellar hypometabolism.
79 were screened; 4 patients developed TLS with clinical symptoms and characteristic changes in laborato
80 (RCTs) assessing the effects of n-3 PUFAs on clinical symptoms and cognition in children and adolesce
81 3 PUFAs supplementation monotherapy improves clinical symptoms and cognitive performances in children
82 ogical tau phases reflected the evolution of clinical symptoms and degeneration on serial antemortem
83  mouse and human recombinant p40 ameliorated clinical symptoms and disease progression of EAE.
84 ation of mumps virus or probable if they had clinical symptoms and either a positive serological test
85 sis is challenging but is primarily based on clinical symptoms and exclusion of other organic causes,
86 , the icPEDV-mut4-infected piglets showed no clinical symptoms and exhibited normal intestinal pathol
87              In this review, we describe the clinical symptoms and genetic/epigenetic features of thi
88 ver, patients with high BMI show more severe clinical symptoms and higher glucose and lipid levels.
89                                 In addition, clinical symptoms and histological damage were more seve
90 athogenicity in dogs, as shown by aggravated clinical symptoms and histopathological changes, increas
91 oral venous obstructions, with reductions in clinical symptoms and improvements in quality of life, t
92 a exacerbations, which leads to worsening of clinical symptoms and may result in a sustained decline
93    Though there was macroscopic bile reflux, clinical symptoms and microscopic changes were minimal.
94  ferrets (<=2 years of age) did not show any clinical symptoms and mortality, SFTSV-infected aged fer
95  results of PET imaging is a valid marker of clinical symptoms and neurodegeneration.
96             Refugees with HBV might not show clinical symptoms and not be diagnosed in destination co
97         Although females can experience both clinical symptoms and obstetrical complications, male in
98 ith CB, but there is a disconnect between CB clinical symptoms and pathology.
99                                              Clinical symptoms and peripheral blood samples from AR s
100              It is important to identify the clinical symptoms and physical examination findings asso
101              The absence of Cdk6 ameliorates clinical symptoms and prolongs survival.
102 eds correlation of actual pollen counts with clinical symptoms and sensitization status to major alle
103                 The pathogenetic mechanisms, clinical symptoms and severity of the disease depend on
104 ons in these biomarkers were associated with clinical symptoms and showed improvement with adjunctive
105 tients at enrolment to the cohort, recording clinical symptoms and signs of depression.
106 eiving systemic and topical antibiotics, her clinical symptoms and signs worsened.
107 rom food intolerant individuals with similar clinical symptoms and strongly suggests the presence of
108 e with no functional B and T cells developed clinical symptoms and succumbed to the infection earlier
109 tress is associated with the exacerbation of clinical symptoms and the induction of recurrences in hu
110 ng immunological tolerance, and reducing the clinical symptoms and the use of medication.
111  NLP to facilitate further analyses of these clinical symptoms and their relevance for prognosis and
112         This hypermethylation was related to clinical symptoms and to a hypoconnectivity between cort
113                                    Cortisol, clinical symptoms and variation in genes, NR3C1 (glucoco
114 ants with PTI were diagnosed on the basis of clinical symptoms and, if available, CT scans and lung b
115  the various organs were not associated with clinical symptoms and, thus, were unrecognized.
116           Patients with PNI may present with clinical symptoms and/or radiologic evidence of PNI (cli
117  post-OIT-FDEIA patients can exhibit similar clinical symptoms, and all symptoms occurred in 60 minut
118 ety of DHA supplementation, its efficacy for clinical symptoms, and changes of brain functional imagi
119 ong variations in protein expression levels, clinical symptoms, and condylar surface morphology.
120 es (rhinitis with/without asthma), different clinical symptoms, and different levels of severity.
121                  FA was defined based on FS, clinical symptoms, and food avoidance.
122 osure to P. falciparum on parasite kinetics, clinical symptoms, and functional immunity after control
123  Plasmodium falciparum on parasite kinetics, clinical symptoms, and functional immunity after control
124 rrelations among measures of EAP, cognition, clinical symptoms, and functional outcome.
125 g, setting, transmission mode, demographics, clinical symptoms, and health outcomes.
126    These patients were monitored for safety, clinical symptoms, and immune reconstitution.
127                        Clinical backgrounds, clinical symptoms, and laboratory findings were compared
128 e, case manager-rated community functioning, clinical symptoms, and self-report measures were assesse
129 een cellular and molecular findings with the clinical symptoms, and this review aims to give an overv
130 age-dependent susceptibility, probability of clinical symptoms, and transmission from asymptomatic (o
131 se mortality, progression to severe disease, clinical symptoms, and upper respiratory virologic clear
132 ta), but Abeta effects may be maximal before clinical symptoms appear.
133 n over the course of years to decades before clinical symptoms appear.
134 ion, with an average time of 439 days before clinical symptoms appeared.
135                                        While clinical symptoms are due to the release of histamine by
136                                              Clinical symptoms are non-distinct and diagnosis mainly
137                                              Clinical symptoms are nonspecific.
138  islet autoimmunity, often many years before clinical symptoms arise.
139  at ultralow concentrations, even before any clinical symptoms arise.
140 most alterations occur prior to the onset of clinical symptoms as a result of pathological manifestat
141 xed models were used to estimate the odds of clinical symptoms associated with new versus persistent
142                              Of this cohort, clinical symptoms at birth and LTI at 6 y of age were re
143 stinal manifestations were the most frequent clinical symptoms at diagnosis and during long-term foll
144       A toxicity grade of 3 or more based on clinical symptoms, bilirubin, ulcer, pancreatitis, ascit
145 igh-dose POMA exerted significant effects on clinical symptoms, but not on target engagement, suggest
146   There were no differences in resolution of clinical symptoms by day 7 or 30-day mortality.
147 ere were no differences in the resolution of clinical symptoms by Day 7 or in 30-day mortality.
148 AA that can be diagnosed before the onset of clinical symptoms by DNA testing.
149                                     Although clinical symptoms can help predict which infants will ha
150                                          The clinical symptoms can mimic those of other chronic disea
151 mour necrosis factor therapy on the basis of clinical symptoms combined with biomarkers in patients w
152 wly or nonresolving LD defined as persistent clinical symptoms, computed tomography (CT) scan abnorma
153 plain differences in sensitizations, unusual clinical symptoms, dependence on drug concentrations, pr
154 iological mechanisms, prompting the specific clinical symptoms, diagnoses, and treatments.
155                    Isolation time, host, and clinical symptoms did not correlate with phylogenetic gr
156  in the mastitis samples and decreased after clinical symptoms disappeared.
157        Th17 cells arrive before the onset of clinical symptoms, distribute uniformly during the peak,
158  which do not necessarily present with overt clinical symptoms early in life and are more likely to b
159 irus infection elicits such a broad range of clinical symptoms, early and accurate laboratory diagnos
160 partially be explained by sex differences in clinical symptoms, etiological models suggest that the b
161 gorithms to integrate chest CT findings with clinical symptoms, exposure history and laboratory testi
162                                              Clinical symptoms, food intolerances and further clinica
163             Mechanical pain serves as a base clinical symptom for many of the world's most debilitati
164  9.6% or 3.7% for all patients or those with clinical symptoms for >48 hours.
165 w-up tests included second-level analyses of clinical symptoms for CT clusters that were significantl
166 espectively), in particular in patients with clinical symptoms for more than 48 hours (95.6%, 93.2%,
167            We delineated regional effects of clinical symptoms, genetic factors, and medication that
168 disease, either asymptomatic or with cardiac clinical symptoms had significantly higher Tc_5171 antig
169  to modify underlying disease and/or improve clinical symptoms have shown promise in preclinical stud
170 ivo because silencing of the INSR attenuated clinical symptoms in animal models of acute graft-versus
171 nto reduced flexible behavior in relation to clinical symptoms in ASD.
172 ervoir for various viruses that rarely cause clinical symptoms in bats but are dangerous zoonotic pat
173 known reasons, viral infections rarely cause clinical symptoms in bats.
174 dulation, respectively, predicting increased clinical symptoms in both groups.
175 aluate the relationship between BMI, Hcy and clinical symptoms in Chinese Han patients with chronic s
176                   Importantly, recovery from clinical symptoms in IBD patients is marked by expansion
177 er valuation measure varied with severity of clinical symptoms in MDD.
178 nction of attention in addition to improving clinical symptoms in MDD.
179 any respects, including (1) lack of apparent clinical symptoms in most cases, (2) persistence of the
180 oncomitant proteinopathies and heterogeneous clinical symptoms in neurodegenerative diseases hinders
181             Stem cell transplant ameliorated clinical symptoms in one patient; forced expression of w
182 known as retigabine) on reward circuitry and clinical symptoms in patients with MDD.
183  whether acute cSAH presents with particular clinical symptoms in patients with probable CAA without
184 ddresses the interpretation of nonlocalizing clinical symptoms in populations with a high prevalence
185 Th17-driven autoimmune response and improved clinical symptoms in psoriatic patients via a defined mo
186 patients experienced significant decrease in clinical symptoms in response to aggressive, transient a
187 toring dystrophin expression and stabilizing clinical symptoms in studies performed on a total of 12
188                     Notably, the early-phase clinical symptoms in the conjunctiva after OVA challenge
189                                              Clinical symptoms include neurodevelopmental regression,
190                                       Common clinical symptoms include pain and clicking.
191 f the disease, most patients experience mild clinical symptoms, including a high fever and dry cough.
192  severity (measured by the 0-5 Gastroparesis Clinical Symptom Index) for nausea (1.8 vs 1.0; P = .005
193 at tics along a spectrum from nonclinical to clinical symptom levels share a similar genetic backgrou
194  that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval
195 dividuals to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatmen
196 er disease (AD) pathology starts long before clinical symptoms manifest, and there is no therapy to t
197 ction with the causing pathogen and onset of clinical symptoms may delay diagnosis of and adequate tr
198 urrently defined as Abeta deposition without clinical symptoms-may be a relatively late manifestation
199 positive intraepithelial lymphocyte density; clinical symptoms measured by gastrointestinal symptom r
200 pacity (indexed as influx rate constant) and clinical symptoms (measured using Positive and Negative
201 ls correlated with less favorable changes in clinical symptom measures, steroid dose required to mana
202 nd the effects of cortisol, demographics and clinical symptoms, NR3C1 variation predicted attention a
203 121 sCJDMM(V)1 (myoclonic type) subjects for clinical symptoms, objective signs and neurophysiologica
204  patients who had a definitive diagnosis and clinical symptoms of AADC deficiency (hypotonia, dystoni
205 ost threefold greater risk of progression to clinical symptoms of AD in men.
206 omised by amyloid pathology years before the clinical symptoms of AD.
207  and does not necessarily correlate with the clinical symptoms of CB.
208 ich can result in spontaneous improvement of clinical symptoms of certain autoimmune diseases includi
209                         PF-06700841 improves clinical symptoms of chronic plaque psoriasis by inhibit
210 minaemia detected in an early stage (without clinical symptoms of damage to the nervous system) durin
211 estigate how Campylobacter jejuni causes the clinical symptoms of diarrhoeal disease in humans, use o
212 s exacerbates MERS-CoV-induced pathology and clinical symptoms of disease.
213 ng memory; and is relevant for understanding clinical symptoms of distractibility and mental inflexib
214 onsistent with its effect on attenuating the clinical symptoms of EAE.
215  alleles in two siblings displaying multiple clinical symptoms of early-onset fatal mitochondrial enc
216 toxicity, contributing to the development of clinical symptoms of envenomation.
217                                   The common clinical symptoms of Friedreich's ataxia (FRDA) include
218                                              Clinical symptoms of gait ataxia, diplopia, cognitive im
219 he study group consisted of 16 patients with clinical symptoms of gastrointestinal bleeding in whom f
220 und that ceria NPs effectively alleviate the clinical symptoms of hepatic IRI by scavenging ROS, inhi
221                              We compared the clinical symptoms of individuals carrying mutations or s
222 ovative therapies to prevent the devastating clinical symptoms of infection.
223 individuals are at higher risk of developing clinical symptoms of MS than the general population.
224  patients, occur before the onset of typical clinical symptoms of neurodegeneration.
225 e strongest and consistent associations with clinical symptoms of OA as well as radiographic evidence
226                    After oral challenge, the clinical symptoms of peanut-induced anaphylaxis were sig
227 ne cell frequencies were associated with the clinical symptoms of the AR subjects and were significan
228 f patients with HCU with PEG-CBS may prevent clinical symptoms of the disease possibly without the ne
229 rveillance system, we assessed patients with clinical symptoms of ZVD from August 9, 2015, to April 2
230 rveillance system, we assessed patients with clinical symptoms of ZVD from August 9, 2015, to April 2
231 ase gene carriers (preHD) far from predicted clinical symptom onset.
232  plasma CMV DNAemia>=1000 IU/ml with/without clinical symptoms or <1000 IU/ml with symptoms.
233 lasma CMV DNAemia >= 1000 IU/mL with/without clinical symptoms or <1000 IU/mL with symptoms.
234 ility to infection, lower propensity to show clinical symptoms or both.
235 ensory processes has relevance for patients' clinical symptoms or cognitive performance.
236 perturbing homeostasis sufficiently to cause clinical symptoms or disease.
237 e was no association between the presence of clinical symptoms or repeat T. vaginalis infections with
238 logy at autopsy had shown few characteristic clinical symptoms or signs of the disease, whereas other
239 butable to the probiotic, either in reducing clinical symptoms or viral nucleic acid clearance from s
240 cells significantly correlated with improved clinical symptoms over the course of AIT.
241 overproduction being a significant driver of clinical symptoms, placental Flt1 mRNA levels strongly c
242 bles (i.e. sex, age, BMI, anatomic location, clinical symptoms, polyp size, and clinical indications
243      Accordingly, in most of those patients, clinical symptoms precisely correlated with grass pollen
244 ures, but they are associated with differing clinical-symptom profiles.
245       Dengue infection induces a spectrum of clinical symptoms, ranging from classical dengue fever t
246 predicts improvements in verbal learning and clinical symptom reduction following a full (30-h) cours
247  of test interruptions than expected, due to clinical symptoms related to a rapid CO2 accumulation in
248  S100a9(-/-) psoriatic mice exhibit worsened clinical symptoms relative to wild-type mice and increas
249 changes perturb brain development and affect clinical symptoms remains elusive.
250 y (amyloid-beta and tau accumulation) before clinical symptoms remains to be elucidated.
251 ere was no association of TVV+ isolates with clinical symptoms, repeat infections, or metronidazole r
252                                  We compared clinical symptoms, risk of EVD diagnosis, and mortality
253                              Associations of clinical symptom scales (attention-deficit/hyperactivity
254 DHD, n-3 PUFAs supplementation improves ADHD clinical symptom scores (g=0.38, p<0.0001); and in three
255                         Secondary outcomes - clinical symptom scores at 2, 3, and 5 years.
256  mass is believed to be a major cause of the clinical symptoms seen in patients with brain cancer.
257 e clusters was also significantly related to clinical symptom severity in the adult PTSD group.
258 e dementia and is characterized by transient clinical symptoms such as fluctuating cognition, which m
259 own to cause cross-sensitization, leading to clinical symptoms such as pollen-food syndrome.
260 nosis of 70% and above might be the cause of clinical symptoms such as transient ischemic attack and
261 fect of childhood trauma before the onset of clinical symptoms, such as anti-inflammatory interventio
262 gies lead to neuronal death and consequently clinical symptoms, such as memory loss, confusion, and i
263 eposition begins decades before the onset of clinical symptoms, suggesting that understanding the bio
264 f these proteases precedes the appearance of clinical symptoms, suggesting their loss may contribute
265 wing to patients' lower ability to mount the clinical symptoms that usually accompany sepsis.
266 ndividuals display a wide variation in their clinical symptoms, the precise neural mechanisms underly
267                       Biomarkers or specific clinical symptoms to identify PTLDS patients do not curr
268 imately mediates intestinal inflammation and clinical symptoms typically observed in patients with IB
269 nt in older adults before the onset of overt clinical symptoms using metabolomics.
270 ated in aged-ferrets that recapitulate fatal clinical symptoms, vaccinated ferrets are completely pro
271 ction of a broad array of neurocognitive and clinical symptom variables at levels comparable to a lea
272                The alcohol responsiveness of clinical symptoms was evaluated by 3 blinded raters with
273  persistence of bacteremia in the absence of clinical symptoms was notable, and markedly different fr
274      Besides demographic characteristics and clinical symptoms, we assessed vaccination status, antiv
275                                              Clinical symptoms were ameliorated with AMG 714 treatmen
276 the detection of anastomotic leakage and its clinical symptoms were analysed.
277                                              Clinical symptoms were assessed before treatment and adv
278                                              Clinical symptoms were assessed retrospectively and comp
279                                              Clinical symptoms were assessed with the Brief Psychiatr
280                                              Clinical symptoms were assessed with the Scale for the A
281                  In addition, the effects on clinical symptoms were assessed.
282                                              Clinical symptoms were commonly absent or mild in severi
283 ath tests (MBT), blood sugar tests (BST) and clinical symptoms were compared with H(2) breath tests (
284            Cumulative chemotherapy doses and clinical symptoms were correlated with the severity of M
285  viremia reached 10 000 copies/mL; otherwise clinical symptoms were observed.
286                              The most common clinical symptoms were painful radiculitis (65.9%), cran
287               Disease severity was assessed; clinical symptoms were recorded.
288 rom cone beam computed tomography (CBCT) and clinical symptoms were used to classify each TMJ data sa
289 monstrated that Sephin1 delayed the onset of clinical symptoms, which correlated with a prolonged int
290 n aggregates and the appearance of the first clinical symptoms, which manifest only after extensive p
291 c studies have derived factors based only on clinical symptoms, which might miss possible links betwe
292  2 (OTX2), can present with a broad range of clinical symptoms, which provides a challenge for predic
293 comorbidity and nonspecificity of presenting clinical symptoms, while demonstrating substantial heter
294 ng framework provides a new means of linking clinical symptoms with biophysically plausible models of
295 n at early stages of disease, prior to overt clinical symptoms with high sensitivity and specificity.
296      A critical factor is the correlation of clinical symptoms with magnetic resonance (MR) imaging f
297 zed individuals were stratified according to clinical symptoms with peach/apple, respectively.
298 5% (12/48) passed the 5000-mg DBPCFC without clinical symptoms, with 10 of these 12 demonstrating sus
299 mount of error reduction correlated with the clinical symptoms, with the most symptomatic patients ad
300  CD4+ </= 200 cells/mul, pregnancy, advanced clinical symptoms (World Health Organization [WHO] stage

 
Page Top